Key facts
- This page summarizes GILEAD SCIENCES, INC.'s Form 3 filing for LEAP THERAPEUTICS, INC. (LPTX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Apr 2024, 16:31.
GILEAD SCIENCES, INC. - 10 Apr 2024 Form 3 Insider Report for LEAP THERAPEUTICS, INC. (LPTX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- LPTX
- Reported as of
- 10 Apr 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 19 Apr 2024, 16:31:02 UTC
- Prior SEC filing
- 03 Apr 2024
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
GILEAD SCIENCES, INC. filed Form 3 for LEAP THERAPEUTICS, INC. (LPTX) on 19 Apr 2024.
Change
- Previous filing in this sequence was filed on 03 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LPTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,319,148
- Date
- 10 Apr 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.